True innovation doesn’t take shortcuts… just unordinary dedication
When it comes to innovative treatments and medical devices that improve lives, our scientists and engineers work at the frontiers of discovery. We work with a pharmaceutical value chain that enables us to get our innovative treatments and devices into the hands of patients who need them – safely and efficiently.
Our efforts are firmly anchored in the Novo Nordisk Way – the principles and values that guide our behaviour. We work with a culture of collaboration, innovation and inclusion, always maintaining a high level of transparency as we openly share our views and engage in respectful scientific debate with one another.
An idea often starts through collaboration with academia and biotech companies from around the world. In the lab, our scientists develop, test and validate ideas, being sure to gether input from the medical community. This helps ensure our focus is 100% aligned with the existing unmet medical needs. To turn an idea into treatment, we must see a potential for lasting and valuable change.
Once we select a promising medicine for further development, it's important to learn how it affects the body and how it interacts with living cells and tissues. After initial testing to see if the medicine works effectively, we then check its safety and potential side effects using animal studies, always prioritizing ethical treatment and care for the animals involved.
Upscaling is the process of getting a promising medicine ready for testing in humans. This involves combining the active ingredient with a safe and easy-to-use product that remains stable and can be produced in large quantities. We carefully develop the methods used to ensure the medicine meets high quality standards and is available in the necessary amounts for clinical trials. Finally, the medicine is packaged and labeled so it can be sent to testing centers around the world.
We work closely with outside experts and healthcare professionals to plan and carry out clinical trials through our network of clinical, medical, and regulatory teams. Our goal is to provide the highest value and quality while making the process as smooth as possible. We also tailor our clinical trials to meet the specific needs of different communities to ensure efficiency and effectiveness.
After successfully finishing a clinical trial program, we need to submit an application to local health authorities in each country where we plan to sell the product. This application includes all the data on how well the medicine works and its safety, gathered from clinical trials, initial testing, and the preparation process. Our team collaborates closely with global health authorities to create clear product labels that help guide patients in using the treatment effectively and achieving the best outcomes.
To keep the medical community informed about new and innovative treatments, we collaborate with various stakeholders to gather, analyse, and share important scientific data and clinical information. Our research and development centers work closely with outside experts and international professional organizations to engage and educate healthcare providers about our medicines, the science that supports them, and the needs they aim to fulfill.
